Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Agilent Technologies, Inc. specializes in providing analytical instruments, software, and services for laboratories in the life sciences, diagnostics, and applied chemical markets. Its competitive position is strengthened by its extensive product portfolio, including mass spectrometry and chromatography systems, primarily serving North America and Europe.
Agilent generates revenue through the sale of high-precision instruments and consumables, alongside software and services. Its strong R&D capabilities allow for continuous innovation, maintaining pricing power and competitive advantages in a market characterized by high barriers to entry.
Regulatory approvals for new diagnostic tests
Trends in healthcare spending, particularly in life sciences research
Market demand for precision medicine and personalized healthcare solutions
Competitive advancements in analytical technologies
Technological disruption from emerging competitors in diagnostic technologies
Regulatory changes impacting the approval process for new products
Increased competition from companies offering lower-cost alternatives
Potential market share loss to startups leveraging innovative technologies
Moderate debt levels could limit financial flexibility in downturns
Potential pension obligations impacting cash flow
moderate - Agilent's performance is somewhat linked to GDP growth and healthcare spending, which can fluctuate with economic cycles.
Rising interest rates may increase financing costs for Agilent, potentially affecting capital expenditures and R&D investments, which could dampen growth prospects.
minimal - Agilent's operations are not heavily reliant on credit markets, given its strong cash flow generation.
growth - due to Agilent's focus on innovation and market expansion in high-growth segments.
moderate - historical beta suggests some sensitivity to market fluctuations, but stable cash flows mitigate extreme volatility.
